Ex-Pharmacy Directors Hit UHS, Drugmakers With FCA Suit

Law360, New York (September 11, 2012, 1:44 PM EDT) -- A Texas federal judge unsealed a False Claims Act complaint Friday targeting Universal Health Services Inc. and several drugmakers, accusing the of the hospital chain of pocketing drug discounts it received from AstraZeneca PLC, Merck & Co. Inc. and other drugmakers instead of passing the savings on to the government.

Two pharmacy directors at UHS-owned hospitals filed the qui tam complaint on behalf of the government, alleging that UHS operated nationwide scheme to leverage any cost-cutting incentives it could get from drugmakers to lower its expenses...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.